Aveanna Healthcare Holdings Inc. AVAH Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 33%-0.3pp | 33.3%-0.3pp | 33.6%+0.2pp | 33.3%+1.2pp | 32.2%+0.8pp | |
| Operating margin | 10.9%+0.3pp | 10.5%+0.4pp | 10.1%+0.4pp | 9.7%+1.7pp | 8.1%+1.2pp | |
| Net margin | 10.4%+1.1pp | 9.2%— | —— | —— | —— | |
| Returns | ||||||
| Return on invested capital | 21.6%+0.8pp | 20.8%+0.8pp | 20%+2.2pp | 17.8%+3.2pp | 14.6%+2.4pp | |
| Efficiency | ||||||
| Asset turnover | 1.4×0.0× | 1.3×0.0× | 1.3×+0.1× | 1.3×0.0× | 1.3×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.5×+0.2× | 1.3×+0.1× | 1.2×+0.1× | 1.1×0.0× | 1×+0.1× | |
| Leverage | ||||||
| Debt-to-equity | 5.6×-1.3× | 6.9×-140× | 146.5×— | —— | —— | |
| Net debt / EBITDA | 4×-0.3× | 4.3×-0.7× | 5×-0.5× | 5.5×-1.5× | 7×-1.3× | |
| Per Share | ||||||
| Book value per share | $1.08+19.5% | $0.90+2,090% | $0.04+172% | -$0.06+88.3% | -$0.49+24.2% | |
| Valuation | ||||||
| Market capitalization | $1.42B-18.9% | $1.75B-7.2% | $1.89B+131% | $818.93M-7.5% | $885.73M-0.3% | |
| Price / earnings | 5.4×-2.4× | 7.8×— | —— | —— | —— | |
| Price / sales | 0.6×-0.2× | 0.7×-0.1× | 0.8×+0.4× | 0.4×0.0× | 0.4×0.0× | |
| Price / book | 5.9×-3.1× | 9×-197× | 205.9×— | —— | —— | |
| EV / EBITDA | 9×-1.9× | 10.9×-1.9× | 12.8×+3.6× | 9.2×-2.7× | 11.9×-2.2× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Aveanna Healthcare Holdings Inc.'s profit margins?
- Aveanna Healthcare Holdings Inc. (AVAH) runs a 33.0% gross margin and a 10.9% operating margin, with a 10.4% net margin.
- Where do Aveanna Healthcare Holdings Inc.'s ratios come from?
- Every ratio is computed from Aveanna Healthcare Holdings Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
